Related Experiment Video
Updated: May 15, 2026
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Efficacy of phytol-derived diterpenoid immunoadjuvants over alum in shaping the murine host's immune response to
Roshni Roy Chowdhury1, Richard W Fitch, Swapan K Ghosh
1Department of Biology, Indiana State University, Terre Haute, IN 47809, USA. rroychowdhu@sycamores.indstate.edu
Abstract:
The ubiquitous gram-positive bacterium Staphylococcus aureus occupies a unique niche in humans for its ability to survive both as a commensal and a life-threatening pathogen. Its complex relationship with the host and its ability to engender a throng of virulence factors, have hindered the development of a successful vaccine against it. The use of immunoadjuvants to enhance host immunity and prevent the shift from commensalism to pathogenicity is a rational approach for containing infection. The objective of this study was to understand the mechanisms by which alum and two phytol-derived immunoadjuvants, phytanol (PHIS-01)(1) and phytanyl chloride (PCl)(2) shape the interaction between S. aureus and its murine host. We studied the effects of the phytol derivatives, relative to alum, on the induction of inflammatory cytokines and chemokines, recruitment of CD11b(+) cells, generation of specific anti-S. aureus antibodies and in vitro clearance of S. aureus. Our results showed that both PHIS-01 and PCl were stronger inducers of protective cytokines IL-17 and IL-1β than alum, and far exceeded alum in enhancing anti-S. aureus antibody response. However, both alum and the phytol derivatives (particularly PCl) promoted efficient recruitment of CD11b(+) cells. Furthermore, PHIS-01, alum and to a lesser extent, PCl were able to up-regulate the expression of key inflammation-related genes that were highly down-regulated by S. aureus alone. In vitro killing assays showed that both PHIS-01 and PCl were far more potent than alum in promoting S. aureus clearance; this indicated their efficiency in shaping an effective anti-S. aureus immune microenvironment. In summary, our study provides evidence for the better effectiveness of phytol-derived immunoadjuvants over alum in enhancing anti-S. aureus immunity.
Insights
Phytol-derived immunoadjuvants, phytanol (PHIS-01) and phytanyl chloride (PCl), show superior immune responses against Staphylococcus aureus compared to alum. These adjuvants enhance protective cytokines, antibody generation, and bacterial clearance, offering a promising strategy for infection control.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Staphylococcus aureus is a common bacterium that can be both harmless and dangerous.
- Developing a vaccine against S. aureus is challenging due to its complex host interactions and virulence factors.
- Immunoadjuvants can enhance the immune system to prevent S. aureus infections.
Purpose of the Study:
- To investigate how alum, phytanol (PHIS-01), and phytanyl chloride (PCl) affect the host's immune response to S. aureus.
- To compare the efficacy of phytol-derived immunoadjuvants with alum in shaping the host-pathogen interaction.
Main Methods:
- Studied the induction of cytokines and chemokines.
- Assessed the recruitment of CD11b(+) immune cells.
- Measured anti-S. aureus antibody production.
- Evaluated in vitro clearance of S. aureus.
- Analyzed the expression of inflammation-related genes.
Main Results:
- PHIS-01 and PCl induced higher levels of IL-17 and IL-1β than alum.
- Phytol derivatives significantly boosted anti-S. aureus antibody responses compared to alum.
- Alum and PCl effectively recruited CD11b(+) cells.
- PHIS-01, alum, and PCl counteracted gene expression changes induced by S. aureus.
- PHIS-01 and PCl demonstrated greater potency in clearing S. aureus in vitro.
Conclusions:
- Phytol-derived immunoadjuvants (PHIS-01 and PCl) are more effective than alum in enhancing anti-S. aureus immunity.
- These adjuvants create a more effective immune environment against S. aureus infections.
- Phytol derivatives represent a promising alternative to alum for S. aureus vaccine development.
